Bigul

Cadila Healthcare Ltd - 532321 - Related Party Disclosure Under Regulation 23(9)

Related Party Disclosure under Regulation 23(9)
18-06-2021
Bigul

CADILA HEALTHCARE LTD. - 532321 - Related Party Disclosure Under Regulation 23(9)

Related Party Disclosure under Regulation 23(9)
18-06-2021

Zydus Cadila's epilepsy drug Brivaracetam gets USFDA tentative nod

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said
14-06-2021
Bigul

CADILA HEALTHCARE LTD. - 532321 - Transcript Of The 1St Extra Ordinary General Meeting Of The Financial Year 2021-2022 Held On June 11, 2021

Transcript of the 1st Extra Ordinary General Meeting of the Financial Year 2021-2022 of the members of the Company held on June 11, 2021
14-06-2021
Bigul

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets
14-06-2021
Bigul

Cadila Healthcare Ltd - 532321 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Cadila Healthcare Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
11-06-2021
Bigul

Cadila Healthcare Ltd - 532321 - Post EOGM Proceedings For The EOGM Held On June 11, 2021

Post EOGM proceedings for the EOGM held on June 11, 2021
11-06-2021
Bigul

Cadila Healthcare Ltd - 532321 - Regulation 44(3) Voting Results EOGM Held On June 11, 2021

Regulation 44(3) voting results EOGM held on June 11, 2021
11-06-2021
Bigul

Cadila Healthcare Ltd - 532321 - Consolidated Results On Voting Of EOGM Along With Scrutinizers'' Report Held On June 11, 2021

Consolidated Results on voting of EOGM along with Scrutinizers'' Report held on June 11, 2021
11-06-2021

Upcoming covid-19 portfolio a shot in the arm for Cadila

Strong growth in the domestic market offset the impact of weak sales in the US in the March quarter
08-06-2021
Next Page
Close

Let's Open Free Demat Account